_version_ 1785075901370728448
author Bergmann, Christina
Müller, Fabian
Distler, Jörg H W
Györfi, Andrea-Hermina
Völkl, Simon
Aigner, Michael
Kretschmann, Sascha
Reimann, Hannah
Harrer, Thomas
Bayerl, Nadine
Boeltz, Sebastian
Wirsching, Andreas
Taubmann, Jule
Rösler, Wolf
Spriewald, Bernd
Wacker, Jochen
Atzinger, Armin
Uder, Michael
Kuwert, Torsten
Mackensen, Andreas
Schett, Georg
author_facet Bergmann, Christina
Müller, Fabian
Distler, Jörg H W
Györfi, Andrea-Hermina
Völkl, Simon
Aigner, Michael
Kretschmann, Sascha
Reimann, Hannah
Harrer, Thomas
Bayerl, Nadine
Boeltz, Sebastian
Wirsching, Andreas
Taubmann, Jule
Rösler, Wolf
Spriewald, Bernd
Wacker, Jochen
Atzinger, Armin
Uder, Michael
Kuwert, Torsten
Mackensen, Andreas
Schett, Georg
author_sort Bergmann, Christina
collection PubMed
description
format Online
Article
Text
id pubmed-10359520
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-103595202023-07-22 Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells Bergmann, Christina Müller, Fabian Distler, Jörg H W Györfi, Andrea-Hermina Völkl, Simon Aigner, Michael Kretschmann, Sascha Reimann, Hannah Harrer, Thomas Bayerl, Nadine Boeltz, Sebastian Wirsching, Andreas Taubmann, Jule Rösler, Wolf Spriewald, Bernd Wacker, Jochen Atzinger, Armin Uder, Michael Kuwert, Torsten Mackensen, Andreas Schett, Georg Ann Rheum Dis Letter BMJ Publishing Group 2023-08 2023-05-05 /pmc/articles/PMC10359520/ /pubmed/37147112 http://dx.doi.org/10.1136/ard-2023-223952 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Letter
Bergmann, Christina
Müller, Fabian
Distler, Jörg H W
Györfi, Andrea-Hermina
Völkl, Simon
Aigner, Michael
Kretschmann, Sascha
Reimann, Hannah
Harrer, Thomas
Bayerl, Nadine
Boeltz, Sebastian
Wirsching, Andreas
Taubmann, Jule
Rösler, Wolf
Spriewald, Bernd
Wacker, Jochen
Atzinger, Armin
Uder, Michael
Kuwert, Torsten
Mackensen, Andreas
Schett, Georg
Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells
title Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells
title_full Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells
title_fullStr Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells
title_full_unstemmed Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells
title_short Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells
title_sort treatment of a patient with severe systemic sclerosis (ssc) using cd19-targeted car t cells
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359520/
https://www.ncbi.nlm.nih.gov/pubmed/37147112
http://dx.doi.org/10.1136/ard-2023-223952
work_keys_str_mv AT bergmannchristina treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT mullerfabian treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT distlerjorghw treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT gyorfiandreahermina treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT volklsimon treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT aignermichael treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT kretschmannsascha treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT reimannhannah treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT harrerthomas treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT bayerlnadine treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT boeltzsebastian treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT wirschingandreas treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT taubmannjule treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT roslerwolf treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT spriewaldbernd treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT wackerjochen treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT atzingerarmin treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT udermichael treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT kuwerttorsten treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT mackensenandreas treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells
AT schettgeorg treatmentofapatientwithseveresystemicsclerosissscusingcd19targetedcartcells